The Top 5 Psychedelics Events to Attend in 2022

Opinions expressed by Entrepreneur contributors are their own.

Many believe that the psychedelics industry today is where cannabis was 10 years ago—a burgeoning market about to burst open. If you’re interested in finding out more about psychedelics, there are plenty of fascinating and informative events happening in cities across the globe. Here are some worth checking out. 

Related: 3 Psychedelic Industry Predictions for 2022


Where: Mediterranean Conference Centre, Valletta, Malta

When:  April 5 to 8, 2022

What: Attendees will gain a diverse and inspiring perspective of the latest advances from the medical cannabis and psychedelics industries through a mix of case-studies presentations, discussions, Q&A sessions, and exhibitions.

The event will focus on six pillars: medical, legislation, business, regulatory, education, and research. Panels will review the international landscape and the opportunities that exist within Europe. Speakers include CEO & Founder of DemeRx, Deborah Mash, one of the world’s foremost experts on the hallucinogenic drug ibogaine, Dr. Alexander Lebedev, Shayla Love, Senior Writer, Vice, Professor for Pharmacy and Head Of Department of Pharmacy, University of Malta, Profs Lillian M. Azzopardi, Chair, Microdose, The Conscious Fund, Richard Skaife, IMIO Life Nextage Therapeutics, Vice Chairman, Dr. Orna Dreazen, Justin Hanka, Co-Founder, MindBio Therapeutics, Director, Capital Markets, Shape Capital.

Deborah C. Mash, Ph.D.

Deborah C. Mash, Ph.D. Photo by Liz Gareri


When: May 19 to 20, 2022 

Where: Oslo, Norway

What: This is a two-day conference on the research of Psychedelic compounds in the Nordic Countries. The program features researchers from Nordic countries as well as international actors. They are continuously updating the program and speakers as the event evolves, however, speakers include Ben Sessa, Chief Medical Officer at AWAKN Life Sciences, Ekaterina Malievskaia, MD. Chief innovation officer and co-founder COMPASS, Dr David Erritzoe, Psychiatrist, London Imperial College – Centre for Psychedelic Research and Atilla Szabo, Neurobiologist, and researcher at Oslo University Hospital to name a few.


When: May 23-24, 2022 

Where: Washington, DC 

What: Following the success of the 1st Annual Psychedelic Therapeutics and Drug Development Conference in 2021, they will now be hosting the 2nd Annual event on May 23-24, 2022 in Washington, DC. This event has been organized to bring together the world’s leading researchers and leaders in academia, industry, the nonprofit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. 

This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

The speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion, and networking.

Speakers include Javier Gonzalez Maeso, Ph.D. Professor for the Virginia Commonwealth University, Berra Yazar-Kosinski, Ph.D. the Chief Scientific Officer for MAPS Public Benefit Corp. and Cody Shandraw Partner of Cambria Capital to name a few. 


When September 22-24, 2022

Where: Philharmonie, Harrlem, and Amsterdam

What: This is the 5th ICPR Conference and features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. The OPEN Foundation has been organizing 5 large and international conferences since 2010

The speakers for this conference include Rick Doblin, Founder and Executive Director of MAPS, the Multidisciplinary Association for Psychedelic Studies, Katrin Preller the Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, David Nichols the Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, and Eric Vermetten, Psychiatrist at Leiden University Medical Center / Ministry of Defence, The Netherlands.

Left to right: Patrick Moher, Rick Doblin, Ph.D., Klee Irwin. Photo by Liz Gareri



Where: Mana Wynwood Convention Center, Miami, Florida

When: November 3 to 5, 2022

What: This event is the largest psychedelic business event in the world. It will last three days in Miami and will boast 5000 like-minded souls seeking information and education on psychedelics.

In addition to the regular conference days, Microdose has added an entire day to their event schedule to dive deep into the art, technology, cultural impact, and experiential transformations of psychedelic medicine. Adventures through virtual reality, breathwork exercises, meditative zones, as well as an art gallery of leading psychedelic artists curated by the team behind one of the world’s foremost art galleries: all of this will be part of your Wonderland experience.


Dr. Robin Carhart-Harris, Ph.D., Ralph Metzner Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape, University of California, San Francisco, Josiah Hesse, The Guardian, Dr. Deborah Mash,  Matthew Johnson, PH.D., Professor of Psychedelics at Johns Hopkins, Psychedelics are just some of the names from last years line up. 

Matthew W. Johnson, Ph.D. Photo by Liz Gareri

Source link

Previous Meet Your Stoner Soulmate On This New Dating App
Next Cresco Labs to Acquire Columbia Care For $2.1B, Creating Largest Cannabis Company in U.S.